TY - JOUR
T1 - Neural basis for the hyperalgesic action of cholecystokinin in the rostral ventromedial medulla
AU - Heinricher, Mary M.
AU - Neubert, Miranda J.
PY - 2004/10
Y1 - 2004/10
N2 - The analgesic actions of opioids can be modified by endogenous "anti-opioid" peptides, among them cholecystokinin (CCK). CCK is now thought to have a broader, pronociceptive role, and contributes to hyperalgesia in inflammatory and neuropathic pain states. The aim of this study was to determine whether anti-opioid and pronociceptive actions of CCK have a common underlying mechanism. We showed previously that a low dose of CCK microinjected into the rostral ventromedial medulla (RVM) blocked the analgesic effect of systemically administered morphine by preventing activation of OFF-cells, which are the antinociceptive output of this well characterized pain-modulating region. At this anti-opioid dose, CCK had no effect on the spontaneous activity of these neurons or on the activity of ON-cells (hypothesized to facilitate nociception) or "NEUTRAL cells" (which have no known role in pain modulation). In this study, we used microinjection of a higher dose of CCK into the RVM to test whether activation of ON-cells could explain the pronociceptive action of this peptide. Paw withdrawal latencies to noxious heat and the activity of a characterized RVM neuron were recorded in rats lightly anesthetized with methohexital. CCK (30 ng/200 nl) activated ON-cells selectively and produced behavioral hyperalgesia. Firing of OFF-cells and NEUTRAL cells was unaffected. These data show that direct, selective activation of RVM ON-cells by CCK is sufficient to produce thermal hyperalgesia and indicate that the anti-opioid and pronociceptive effects of this peptide are mediated by actions on different RVM cell classes.
AB - The analgesic actions of opioids can be modified by endogenous "anti-opioid" peptides, among them cholecystokinin (CCK). CCK is now thought to have a broader, pronociceptive role, and contributes to hyperalgesia in inflammatory and neuropathic pain states. The aim of this study was to determine whether anti-opioid and pronociceptive actions of CCK have a common underlying mechanism. We showed previously that a low dose of CCK microinjected into the rostral ventromedial medulla (RVM) blocked the analgesic effect of systemically administered morphine by preventing activation of OFF-cells, which are the antinociceptive output of this well characterized pain-modulating region. At this anti-opioid dose, CCK had no effect on the spontaneous activity of these neurons or on the activity of ON-cells (hypothesized to facilitate nociception) or "NEUTRAL cells" (which have no known role in pain modulation). In this study, we used microinjection of a higher dose of CCK into the RVM to test whether activation of ON-cells could explain the pronociceptive action of this peptide. Paw withdrawal latencies to noxious heat and the activity of a characterized RVM neuron were recorded in rats lightly anesthetized with methohexital. CCK (30 ng/200 nl) activated ON-cells selectively and produced behavioral hyperalgesia. Firing of OFF-cells and NEUTRAL cells was unaffected. These data show that direct, selective activation of RVM ON-cells by CCK is sufficient to produce thermal hyperalgesia and indicate that the anti-opioid and pronociceptive effects of this peptide are mediated by actions on different RVM cell classes.
UR - http://www.scopus.com/inward/record.url?scp=4444328321&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=4444328321&partnerID=8YFLogxK
U2 - 10.1152/jn.00411.2004
DO - 10.1152/jn.00411.2004
M3 - Article
C2 - 15152023
AN - SCOPUS:4444328321
SN - 0022-3077
VL - 92
SP - 1982
EP - 1989
JO - Journal of neurophysiology
JF - Journal of neurophysiology
IS - 4
ER -